InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the detailed record of transactions filed by MCGRAW BENJAMIN F III, Director. Director active across 1 company, notably Aerie Pharmaceuticals INC. Aggregated, 7 reports have been recorded. Activity tracked since 17 June 2021. The latest transaction was filed on 21 November 2022 (Disposition). Regulator: SEC (Form 4). The full history is openly available.
Declarations7 total
41,984 shares@ US$15.2589.0% of flowCommon StockSEC:0001209191-22-058189:0
6,245 shares0Common StockSEC:0001209191-22-036397:0
10,324 shares@ US$8.30100.0% of flowCommon StockSEC:0001209191-22-014974:0
34,513 shares0Common StockSEC:0001209191-21-057288:0
34,513 shares0Common StockSEC:0001209191-21-057288
1,750 shares0Common StockSEC:0001209191-21-042031
1,750 shares0Common StockSEC:0001209191-21-042031:0
7 of 7 declarations
About MCGRAW BENJAMIN F III
Benjamin F. McGraw III is a Board Member and Interim Executive Chairman at AERIE PHARMACEUTICALS INC. He plays a key role in the governance of the company, participating in strategic decision-making and guiding operations. His experience in the pharmaceutical sector is valuable to the board, allowing AERIE to focus on innovation and growth.
